Skip to main content
Wolfgang Bergmeier, PhD

5 years ago

Wolfgang Bergmeier appointed to Haima Therapeutics Scientific Advisory Board

Haima Therapeutics, a pre-clinical biotechnology company focused on developing platelet-inspired therapies to mitigate bleeding dysfunctions, announced today the appointment of Wolfgang Bergmeier to its Scientific Advisory Board (SAB). Dr. Bergmeier is a world-renowned scientist and key opinion leader in platelet biology, hemostasis, and thrombosis. He is currently a Professor of Biochemistry and Biophysics at The …

Dale Ramsden and Gaorav Gupta

5 years ago

Ramsden, Gupta awarded 5-year, $8.8 million grant to study an enzyme that has important implications for breast and ovarian cancer

The National Cancer Institute has awarded a team led by UNC Lineberger’s Dale Ramsden, PhD, professor in the UNC School of Medicine Department of Biochemistry and Biophysics, a five-year, $8.8 million program project grant to study an enzyme called DNA polymerase theta. This enzyme is part of an important pathway that repairs damage to genomes, with particular significance …